Skip to content

Eli Lilly and Company Price, Chart & Factor Exposure

Free Data & Analytics Access
Eli Lilly and Company · E.LLY.NEO · Canada
Use symbol E.LLY.NEO in our API & Excel add-in to retrieve this data ↓
—
(—)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum —
Trend —
Bubble Risk LOW
Realised Volatility (20D) —

Eli Lilly and Company Price Chart

MacroFinance.ai

Eli Lilly and Company Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Eli Lilly and Company
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Eli Lilly and Company
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Eli Lilly and Company
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Eli Lilly and Company, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Eli Lilly and Company

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

About Eli Lilly and Company (Canada)

Eli Lilly and Company is a listed security in Canada. This page shows the latest price and daily change, a price chart, its factor exposures and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Eli Lilly and Company

Frequently asked questions

What is Eli Lilly and Company?
Eli Lilly and Company is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, its factor exposures and free historical data.
What factors affect Eli Lilly and Company?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Eli Lilly and Company, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Where can I download free Eli Lilly and Company historical data?
In the Free historical data section of this page: the last 10 years of Eli Lilly and Company daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Eli Lilly and Company historical data (last 10 years)

Browse or instantly download the last 10 years of Eli Lilly and Company daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.LLY.NEO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-05-2939.78
2026-05-2840.61
2026-05-2739.09
2026-05-2638.48
2026-05-2539.07
2026-05-2238.37
2026-05-2137.53
2026-05-2036.63
2026-05-1936.76
2026-05-1536.23
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd; Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease, as well as Strategic partnership with NVIDIA Corporation. The company also has a research collaboration agreement with Insilico Medicine for the development of advance therapies. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.